Charles Schwab Investment Management Inc. increased its position in shares of Provident Financial Services, Inc. (NYSE:PFS – Free Report) by 1.9% during the fourth quarter, HoldingsChannel reports.
2mon
Medpage Today on MSNBig PFS Increase in Advanced Neuroendocrine Tumors With Combination TherapySeveral studies have suggested that adding an SSA to everolimus might extend PFS. The Japan Clinical Oncology Group JCOG1901 (STARTER-NET) trial compared outcomes with single-agent everolimus ...
Principal Financial Group Inc. boosted its position in Provident Financial Services, Inc. (NYSE:PFS – Free Report) by 2.9% during the 4th quarter, HoldingsChannel.com reports.The firm owned ...
Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results